Sha Q. Ma
No. 99 West Huaihai Road
Xuzhou, 221002, China
Xuzhou, 221002, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Anti-BCMA/GPRC5D CAR T cells in patients with relapsed or refractory multiple myeloma who have extraosseous extramedullary disease.
Journal: Blood
Published: February 03, 2026
Concurrent monomorphic epitheliotropic intestinal T-cell lymphoma with aberrant CD20 expression and lung adenocarcinoma: A case report and literature review.
Journal: Cancer treatment and research communications
Published: October 10, 2025
The impact of antibiotic use on outcomes of relapsed/refractory multiple myeloma patients treated with CAR-T therapy.
Journal: Frontiers in immunology
Published: January 24, 2025
Lymphocyte/monocyte to lactate dehydrogenase ratio prior to lymphodepletion impact the outcomes of patients with diffused large B cell lymphoma undergoing CAR-T cell therapy.
Journal: Cancer immunology, immunotherapy : CII
Published: November 20, 2024
Rare VPS33B gene mutation combined with GP1BA mutation causes severe decrease in plasma VWF levels: a case report and literature review
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: August 12, 2024
Anti-BCMA/GPRC5D bispecific CAR T cells in patients with relapsed or refractory multiple myeloma: a single-arm, single-centre, phase 1 trial.
Journal: The Lancet. Haematology
Published: March 10, 2024
Associations of granulocyte colony-stimulating factor with toxicities and efficacy of chimeric antigen receptor T-cell therapy in relapsed or refractory B-cell acute lymphoblastic leukemia.
Journal: Cancer immunology, immunotherapy : CII
Published: January 12, 2024
Factors associated with infection events after chimeric antigen receptor T-cell therapy for relapsed or refractory multiple myeloma.
Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
Published: August 30, 2022
Associations of granulocyte colony-stimulating factor with toxicities and efficacy of chimeric antigen receptor T-cell therapy in relapsed or refractory multiple myeloma.
Journal: Cytotherapy
Published: August 18, 2022
Efficacy and safety of CD19-specific CAR-T cell-based therapy in secondary central nervous system lymphoma.
Journal: Frontiers in immunology
Published: June 09, 2022
Last Updated: 09/26/2026